Immunome (IMNM) - P/B ratio
P/B ratio as of April 2025 : 2.98
According to Immunome's latest financial reports the company has a price-to-book ratio of 59.6277.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
P/B ratio by year
Year |
P/B ratio |
Change |
2024-12-31 | 3.63 | -4.78% |
2023-12-31 | 3.81 | 136.94% |
2022-12-31 | 1.61 | -50.54% |
2021-12-31 | 3.25 | 31.87% |
2020-12-31 | 2.47 | |
2019-12-31 | N/A | |
P/B ratio for similar companies or competitors
Company | P/B ratio | P/B ratio differencediff. | Country |
| 1.37 | -53.85% | ๐บ๐ธ USA |